Login / Signup

Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.

Susan CuvelierPaul Van CaeseeleMatthew J KadatzKathryn PetersonSiyao SunNancy DoddKim WerestiukJoshua KoulackPeter NickersonJulie Ho
Published in: Canadian journal of kidney health and disease (2021)
The goal of this quality improvement project is to improve access to kidney transplantation for Manitobans. This program will provide prophylactic DAA therapy for HCV-viremic kidney transplant to HCV-naïve recipients as routine standard of care outside a clinical trial protocol. We anticipate this program will be a safe and effective way to expand kidney transplantation from a previously unutilized donor pool.
Keyphrases
  • kidney transplantation
  • quality improvement
  • patient safety
  • clinical trial
  • hepatitis c virus
  • randomized controlled trial
  • phase ii
  • hiv infected
  • antiretroviral therapy
  • affordable care act